1. Home
  2. INDP vs CTNT Comparison

INDP vs CTNT Comparison

Compare INDP & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • CTNT
  • Stock Information
  • Founded
  • INDP 2000
  • CTNT 2016
  • Country
  • INDP United States
  • CTNT United States
  • Employees
  • INDP N/A
  • CTNT N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • CTNT
  • Sector
  • INDP Health Care
  • CTNT
  • Exchange
  • INDP Nasdaq
  • CTNT Nasdaq
  • Market Cap
  • INDP 10.2M
  • CTNT 9.4M
  • IPO Year
  • INDP N/A
  • CTNT 2023
  • Fundamental
  • Price
  • INDP $0.84
  • CTNT $2.43
  • Analyst Decision
  • INDP Strong Buy
  • CTNT Hold
  • Analyst Count
  • INDP 2
  • CTNT 1
  • Target Price
  • INDP $8.50
  • CTNT N/A
  • AVG Volume (30 Days)
  • INDP 25.3K
  • CTNT 168.7K
  • Earning Date
  • INDP 03-12-2025
  • CTNT 11-13-2024
  • Dividend Yield
  • INDP N/A
  • CTNT N/A
  • EPS Growth
  • INDP N/A
  • CTNT N/A
  • EPS
  • INDP N/A
  • CTNT N/A
  • Revenue
  • INDP N/A
  • CTNT $7,703,113.00
  • Revenue This Year
  • INDP N/A
  • CTNT N/A
  • Revenue Next Year
  • INDP N/A
  • CTNT N/A
  • P/E Ratio
  • INDP N/A
  • CTNT N/A
  • Revenue Growth
  • INDP N/A
  • CTNT N/A
  • 52 Week Low
  • INDP $0.81
  • CTNT $1.70
  • 52 Week High
  • INDP $3.10
  • CTNT $236.16
  • Technical
  • Relative Strength Index (RSI)
  • INDP 39.07
  • CTNT 38.81
  • Support Level
  • INDP $0.86
  • CTNT $2.33
  • Resistance Level
  • INDP $1.06
  • CTNT $2.75
  • Average True Range (ATR)
  • INDP 0.08
  • CTNT 0.23
  • MACD
  • INDP 0.00
  • CTNT -0.09
  • Stochastic Oscillator
  • INDP 12.80
  • CTNT 8.93

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.

Share on Social Networks: